Literature DB >> 30624988

Potential Strategies to Reduce Blood Pressure in Treatment-Resistant Hypertension Using Food and Drug Administration-Approved Nanodrug Delivery Platforms.

Ibra S Fancher1, Israel Rubinstein1,2, Irena Levitan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30624988      PMCID： PMC6338082          DOI： 10.1161/HYPERTENSIONAHA.118.12005

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  67 in total

1.  Antihypertensive nano-ceuticales based on chitosan biopolymer: Physico-chemical evaluation and release kinetics.

Authors:  Taskeen Niaz; Saima Shabbir; Shahid Manzoor; Asma Rehman; Abdur Rahman; Habib Nasir; Muhammad Imran
Journal:  Carbohydr Polym       Date:  2016-01-25       Impact factor: 9.381

Review 2.  Decoding resistant hypertension signalling pathways.

Authors:  Ricardo Cambraia Parreira; Leandro Heleno Guimarães Lacerda; Rebecca Vasconcellos; Swiany Silveira Lima; Anderson Kenedy Santos; Vanessa Fontana; Valéria Cristina Sandrim; Rodrigo Ribeiro Resende
Journal:  Clin Sci (Lond)       Date:  2017-11-28       Impact factor: 6.124

Review 3.  Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date.

Authors:  Daniel Bobo; Kye J Robinson; Jiaul Islam; Kristofer J Thurecht; Simon R Corrie
Journal:  Pharm Res       Date:  2016-06-14       Impact factor: 4.200

Review 4.  Resistant Hypertension: Mechanisms and Treatment.

Authors:  Andrew Y Hwang; Eric Dietrich; Carl J Pepine; Steven M Smith
Journal:  Curr Hypertens Rep       Date:  2017-07       Impact factor: 5.369

5.  Nanoparticles targeting the infarcted heart.

Authors:  Tal Dvir; Michael Bauer; Avi Schroeder; Jonathan H Tsui; Daniel G Anderson; Robert Langer; Ronglih Liao; Daniel S Kohane
Journal:  Nano Lett       Date:  2011-09-14       Impact factor: 11.189

Review 6.  Felodipine. A review of the pharmacology and therapeutic use of the extended release formulation in cardiovascular disorders.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

7.  Increased biological half-life of aerosolized liposomal recombinant human Cu/Zn superoxide dismutase in pigs.

Authors:  Martin Kaipel; Andreas Wagner; Esther Wassermann; Karola Vorauer-Uhl; Richard Kellner; Heinz Redl; Hermann Katinger; Roman Ullrich
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2008-09       Impact factor: 2.849

8.  Emerging nanomedicine applications and manufacturing: progress and challenges.

Authors:  Felicity Sartain; Francesca Greco; Kathryn Hill; Steve Rannard; Andrew Owen
Journal:  Nanomedicine (Lond)       Date:  2016-02-25       Impact factor: 5.307

Review 9.  Nanocarriers as treatment modalities for hypertension.

Authors:  Tausif Alam; Saba Khan; Bharti Gaba; Md Faheem Haider; Sanjula Baboota; Javed Ali
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE) - inhibitory biopeptides by chitosan nanoparticles optimized using Box-Behnken design.

Authors:  Shehu Muhammad Auwal; Mohammad Zarei; Chin Ping Tan; Mahiran Basri; Nazamid Saari
Journal:  Sci Rep       Date:  2018-07-10       Impact factor: 4.379
View more
  3 in total

1.  Role of Organic and Inorganic Nanoparticles in the Drug Delivery System for Hypertension Treatment: A Systematic Review.

Authors:  Nasrollah Moradifar; Ali Asghar Kiani; Atefe Veiskaramian; Kimia Karami
Journal:  Curr Cardiol Rev       Date:  2022

Review 2.  Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives.

Authors:  Natasha Manners; Vishnu Priya; Abhishesh Kumar Mehata; Manoj Rawat; Syam Mohan; Hafiz A Makeen; Mohammed Albratty; Ali Albarrati; Abdulkarim M Meraya; Madaswamy S Muthu
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-01

Review 3.  Redox Switches Controlling Nitric Oxide Signaling in the Resistance Vasculature and Implications for Blood Pressure Regulation: Mid-Career Award for Research Excellence 2020.

Authors:  Atinuke Aramide Modupe Dosunmu-Ogunbi; Joseph C Galley; Shuai Yuan; Heidi M Schmidt; Katherine C Wood; Adam C Straub
Journal:  Hypertension       Date:  2021-08-23       Impact factor: 9.897
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.